Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01867489
Other study ID # B322201214929
Secondary ID
Status Completed
Phase N/A
First received May 19, 2013
Last updated November 17, 2014
Start date September 2012
Est. completion date January 2014

Study information

Verified date November 2014
Source Universitaire Ziekenhuizen Leuven
Contact n/a
Is FDA regulated No
Health authority Belgium: The Federal Public Service (FPS) Health, Food Chain Safety and Environment
Study type Observational

Clinical Trial Summary

This qualitative study explores how patients deal with the side effects from chemotherapy at their home, what factors and ideas influence their symptom self-management and how professional caregivers contribute to the management of their symptoms at home. Data are collected through semi-structured interviews with adult patients treated with chemotherapy and analysed using a Grounded Theory approach.


Recruitment information / eligibility

Status Completed
Enrollment 28
Est. completion date January 2014
Est. primary completion date January 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Adult (=18 years) patients with (any type and any stage of) cancer who were undergoing chemotherapy treatment in an ambulatory setting or during short hospital stays

- Dutch speaking

- Able to provide informed consent and to participate in an interview

Exclusion Criteria:

- Patients who were in the first 2 cycles of treatment

- Patients for whom an interview was considered physically, mentally and/or emotionally too burdensome.

- Patients who had reported not to experience any side effect from treatment at all

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms

  • Exploration of How Patients Deal With Side Effects From Chemotherapy

Intervention

Other:
No intervention


Locations

Country Name City State
Belgium UZ Leuven Leuven

Sponsors (1)

Lead Sponsor Collaborator
Universitaire Ziekenhuizen Leuven

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary patient's experience one interview during the course of treatment, i.e. one timepoint between 2 months after the start of chemotherapy and the end of the patient's treatment No